SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells

By            

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 269-275

Spandidos Publications

Access to resources Recommend Favorite

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

By Wobser Marion   Voigt Heike   Houben Roland   Eggert Andreas   Freiwald Matthias   Kaemmerer Ulrike   Kaempgen Eckhart   Schrama David   Becker Juergen  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1017-1024

Springer Publishing Company

Access to resources Recommend Favorite

Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells

By El Kholy Noura  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 270-278

Humana Press, Inc

Access to resources Recommend Favorite

(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells

By                      

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 546-550

Spandidos Publications

Access to resources Recommend Favorite

Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy

By                      

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 929-934

Spandidos Publications

Access to resources Recommend Favorite